| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| FON_NAZ - Bandi Altre Fondazioni |
The natural antisense lncRNA PHOX2B-AS1 in the pathogenesis and as potential drug target in Congenital Central Hypoventilation Syndrome (CCHS)
|
|
Ongoing | 2023 |
| MIS - Bandi Ministero Salute |
The role of oxidative stress and mitochondrial TERT in the progression and therapeutic resistance of papillary thyroid cancer (TEMPEST)
|
|
Ongoing | 2021 |
| FISR - Fondo integrativo speciale per la ricerca |
Test rapido di contagiosità da COVID-19: sviluppo di un biosensore per misurare la presenza del virus intero nell'esalato respiratorio (VIAEREA)
|
|
Closed | 2021 |
| MIS - Bandi Ministero Salute |
Temozolomide in the chemo-immuno-therapy of refractory acute leukaemia of adult patients: the TRIAC protocol
|
|
Closed | 2009 |
| CLUST - Cluster Tecnologici Nazionali (MIUR) |
Tecnologie convergenti per aumentare la sicurezza e l'efficacia di biofarmaci e vaccini
|
|
Closed | 2015 |
| INTLI - Finanziamenti internazionali |
Technologies for Non-Equilibrium Systems (TechNES)
|
|
Closed | 2020 |
| PRIN2022 - PRIN bando 2022 |
Targeting the overlapping mechanisms inducing immune cell dysfunctions and autoimmunity in the pathophysiology of Thymic Epithelial Tumors.
|
|
Ongoing | 2023 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Targeting the lymphatics as a new strategy in cancer immunotherapy
|
|
Closed | 2011 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Targeting the lymphatics as a new strategy in cancer immunotherapy
|
|
Closed | 2009 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Targeting the lymphatics as a new strategy in cancer immunotherapy
|
|
Closed | 2010 |
